PAFAH1B3 and cancer: PAFAH1B3 has been proposed as a driver cancer gene [46], while AHCYL2, which is highly expressed in the gastrointestinal tract [47], has been found to be highly downregulated in the gene expression profiling of colorectal tumour [48].